These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26645049)

  • 1. Targeting Transcription Factors in Cancer.
    Bhagwat AS; Vakoc CR
    Trends Cancer; 2015 Sep; 1(1):53-65. PubMed ID: 26645049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of pioneer transcription factors in targeted ERα positive breast cancer.
    Pavithran H; Kumavath R
    Explor Target Antitumor Ther; 2021; 2(1):26-35. PubMed ID: 36046086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current strategies and progress for targeting the "undruggable" transcription factors.
    Zhuang JJ; Liu Q; Wu DL; Tie L
    Acta Pharmacol Sin; 2022 Oct; 43(10):2474-2481. PubMed ID: 35132191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer.
    Manzar N; Ganguly P; Khan UK; Ateeq B
    Semin Cancer Biol; 2023 Feb; 89():76-91. PubMed ID: 36702449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription Factors in Prostate Cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches.
    Silva KCS; Tambwe N; Mahfouz DH; Wium M; Cacciatore S; Paccez JD; Zerbini LF
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets.
    Nameki R; Chang H; Reddy J; Corona RI; Lawrenson K
    Pharmacol Ther; 2021 Apr; 220():107722. PubMed ID: 33137377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting post-translational modification of transcription factors as cancer therapy.
    Qian M; Yan F; Yuan T; Yang B; He Q; Zhu H
    Drug Discov Today; 2020 Aug; 25(8):1502-1512. PubMed ID: 32540433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors in the development and treatment of immune disorders.
    Patalano SD; Fuxman Bass P; Fuxman Bass JI
    Transcription; 2023 Dec; ():1-23. PubMed ID: 38100543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting transcription factors in multiple myeloma: evolving therapeutic strategies.
    Li S; Vallet S; Sacco A; Roccaro A; Lentzsch S; Podar K
    Expert Opin Investig Drugs; 2019 May; 28(5):445-462. PubMed ID: 30963799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas.
    Garces de Los Fayos Alonso I; Liang HC; Turner SD; Lagger S; Merkel O; Kenner L
    Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29597249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy.
    Khan AQ; Hasan A; Mir SS; Rashid K; Uddin S; Steinhoff M
    Semin Cancer Biol; 2024 May; 100():1-16. PubMed ID: 38503384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupted cooperation between transcription factors across diverse cancer types.
    Wang J; Liu Q; Sun J; Shyr Y
    BMC Genomics; 2016 Aug; 17():560. PubMed ID: 27496222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?
    Marqués M; Sorolla MA; Urdanibia I; Parisi E; Hidalgo I; Morales S; Salud A; Sorolla A
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atlas of regulated target genes of transcription factors (ART-TF) in human ES cells.
    Sharov AA; Nakatake Y; Wang W
    BMC Bioinformatics; 2022 Sep; 23(1):377. PubMed ID: 36114445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in targeting 'undruggable' transcription factors with small molecules.
    Henley MJ; Koehler AN
    Nat Rev Drug Discov; 2021 Sep; 20(9):669-688. PubMed ID: 34006959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing therapeutic signatures of transcription factors in cancer by incorporating profiles in compound treated cells.
    Jung J
    Bioinformatics; 2021 May; 37(7):1008-1014. PubMed ID: 32886093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic target function annotation of human transcription factors.
    Li YF; Altman RB
    BMC Biol; 2018 Jan; 16(1):4. PubMed ID: 29325558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating miRNA-related Pathways Contributing to Kidney Cancer Pathogenesis.
    Yousef P; Ibrahim R; Boulos C; Khatab Z; Pasic M; Krizova A
    Anticancer Res; 2022 May; 42(5):2355-2362. PubMed ID: 35489756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting DNA binding proteins for cancer therapy.
    Shiroma Y; Takahashi RU; Yamamoto Y; Tahara H
    Cancer Sci; 2020 Apr; 111(4):1058-1064. PubMed ID: 32073717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TF-PROTACs Enable Targeted Degradation of Transcription Factors.
    Liu J; Chen H; Kaniskan HÜ; Xie L; Chen X; Jin J; Wei W
    J Am Chem Soc; 2021 Jun; 143(23):8902-8910. PubMed ID: 34100597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.